Actavis
Also known as: ACTAVIS | ACTAVIS ELIZABETH | Actavis Group | ACTAVIS GROUP | ACTAVIS GRP PTC | Actavis Inc. | ACTAVIS INC | ACTAVIS LABS | ACTAVIS LABS FL | ACTAVIS LABS FL INC | ACTAVIS LABS NY INC | ACTAVIS LABS UT INC | ACTAVIS LLC | ACTAVIS MID ATLANTIC | Actavis Mid-Atlantic LLC | ACTAVIS PHARMA | ACTAVIS TOTOWA | ACTAVIS TOTOWA TEVA | Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) | Forest Laboratories, Inc. a subsidiary of Actavis plc | Forest Research Institute, a subsidiary of Actavis plc.
Highest phase reached
Phase 3
Timeline
1990s
- Apr 5, 1996
minoxidil— Marketing Organization
2000s
- Mar 18, 2005
Lotus Labs— Acquired
2010s
- Jan 1, 2012
Actavis— Founded
- Apr 25, 2012
Watson Pharmaceuticals— Acquired
- Jan 1, 2013
Warner Chilcott— Acquired
- Apr 12, 2013
docetaxel— NDA Secondary Org
- Apr 1, 2014
Silom Medical Company— Acquired
- Jul 1, 2014
Forest Laboratories— Acquired
- Oct 6, 2014
Durata— Acquired
- Mar 17, 2015
Allergan PLC (2015)— Acquired By
- Jun 1, 2015
Auden Mckenzie Holdings Ltd.— Acquired
- Jun 26, 2019
AbbVie— Now
Drugs by trial phase (330 distinct, 946 trials)
Phase 4 (0 own, 59 via acquisition)
Phase 3 (23 own, 80 via acquisition)
Phase 2 (0 own, 78 via acquisition)
Phase 1 (22 own, 49 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Acute Pain
- Ankle Injuries
- Anxiety Disorders
- Asthma
- Atrophic Vaginitis
- Atrophy
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Cataract
- Celiac Disease
- Depression
- Depressive Disorder
- Dermatitis
- Dermatitis, Atopic
- Diarrhea
- Disease
- Eczema
- Erythema
- Glaucoma
- Glaucoma, Open-Angle
- Hypertension
- Inflammation
- Keratosis
- Keratosis, Actinic
- Lice Infestations
- Lung Neoplasms
- Major Depressive Disorder
- Malnutrition
- Ocular Hypertension
- Osteomyelitis
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Rosacea
- Schizophrenia
- Signs and Symptoms
- Sprains and Strains
- Vaginal Discharge
- Vaginal Diseases
- Vaginitis
- Vaginosis, Bacterial
Marketed drugs (243)
Subsidiaries (7 direct, 87 total across the full acquisition tree)
- Auden Mckenzie Holdings Ltd.
- Durata
- Forest Laboratories
- Lotus Labs
- Silom Medical Company
- Warner Chilcott
- Watson Pharmaceuticals
- Actavis Group (1956) L2
- Andrx L2
- Aptalis L2
- Ascent Pharmahealth L2
- Cerexa L2
- Circa Pharmaceuticals L2
- Clinical Data, Inc. L2
- Eden Biodesign L2
- Furiex L2
- Galen L2
- Halsey L2
- Henry Schein, Inc L2
- Nalé Laboratories, PLC L2
- Oclassen L2
- Procter and Gamble L2
- Specifar Pharmaceuticals S.A. L2
- Uteron Pharma S.A. L2
- Accord Dental L3
- Alpha Scientific L3
- Arcona L3
- Armstrong Pharmaceuticals L3
- Ash Temple L3
- Axcan L3
- Barton-Cyker Dental Supply L3
- Butler Animal Health L3
- Caligor Hospital L3
- Colonial Surgical L3
- CTEX Pharmaceuticals L3
- Dentrix Dental Systems L3
- Eurand Pharmaceuticals L3
- Genaissance L3
- GIV L3
- Hager Dental L3
- Halas Dental L3
- Heiland L3
- ImproMed L3
- Krugg L3
- Lincoln Dental Supply L3
- Maravet L3
- Marsam Pharmaceuticals L3
- McAllister Software Systems L3
- Medivet S.A. L3
- Medka L3
- Meer Dental L3
- Minerva Dental, Ltd L3
- Modern Laboratory Services L3
- New Chapter Inc L3
- Nioxin Research Laboratories L3
- NLS Animal Health L3
- Norwich Eaton Company L3
- Noviko L3
- Noxell L3
- Ortho Oganizers L3
- Ortho Technology L3
- Permira L3
- Provet Holding AG L3
- Regional Healthcare (Australia) L3
- Richardson Vicks Inc L3
- RxWorks L3
- Scil Technology GmbH L3
- Shalfoon Brothers L3
- Software of Excellence International, Ltd. L3
- Sogim Grimouille L3
- Sullivan Dental Products L3
- Thomas Hedley Co L3
- Vertex L3
- W&J Dunlop Ltd L3
- Zahn Dental L3
- Alpine Immune Sciences L4
- Aurora Biosciences L4
- Exonics L4
- J.T. Baker Chemical Company L4
- Milton Antiseptic L4
- Muller & Weygandt L4
- Prince Matchabelli Perfume Company L4
- Semma Therapeutics L4
- ViaCyte L4
- ViroChem Pharma L4
- William S. Merrell Company L4
- Nivalis Therapeutics, Inc. L5
Recent trials (50)
- NCT05577000CollaboratorPhase 1Mar 1, 2023
- NCT03954444Lead sponsorPhase 3Apr 15, 2019
- NCT03879837Lead sponsorPhase 3Mar 25, 2019
- NCT03756883Lead sponsorPhase 3Dec 3, 2018
- NCT03499873Lead sponsorPhase 3Mar 28, 2018
- NCT03301649Lead sponsorPhase 3Oct 7, 2017
- NCT03200912Study directorPhase 3Aug 19, 2016
- NCT03200912Lead sponsorPhase 3Aug 19, 2016
- NCT03287791Lead sponsorPhase 3Jul 19, 2016
- NCT02498418Lead sponsorPhase 3Jun 1, 2016
- NCT02840461Lead sponsorPhase 3Jun 1, 2016
- NCT02498418Study directorPhase 3Jun 1, 2016
- NCT03294538Lead sponsorPhase 3May 18, 2016
- NCT02344511Lead sponsorPhase 3Mar 1, 2016
- NCT02495168Lead sponsorPhase 3Nov 1, 2015
Details
- Founded
- Parsippany, NJ, US Jan 1, 2012
- Last known activity
- Mar 1, 2023
Notes
Acquired by Teva